Our CSO Prof David Kendall is co-organizer of a British Pharmacological Society-sponsored symposium at the 2018 ELRIG Drug Discovery meeting in London in October (Read here). The symposium entitled “The opioid crisis, addiction and the search for more effective analgesics”, will bring together industrial and academic pain research experts andRead More →

David Kendall and Bengt von Mentzer gave the first public presentations of PN6047, PharmNovo’s biased delta opioid receptor agonist, at the European Neuropeptide Conference in Aberdeen (28th September-1st October). Their descriptions of the molecular mechanisms and in vivo effects of the compound generated a good deal of interest from theRead More →